Tim Seymour

On CNBC's “Halftime Report Final Trades,” Tim Seymour of Seymour Asset Management picked Cameco Corporation (NYSE:CCJ). On Nov. 7, Cameco posted a loss for the third quarter but raised its FY24 revenue guidance. Julie Biel of Kayne Anderson Rudnick named West Pharmaceutical Services,...

Rate cut expectations have driven up risk appetite in the last two months, and equity investors have been pushing up stocks at both ends of the market capitalization spectrum. Now could be a good time to focus on the large multinationals, says one market expert. Tim Seymour, founder and CIO at...

On this Cannabis Exclusive Podcast, TDR Founder Shadd Dales and contributor Anthony Varrell spoke with Tim Seymour. Mr. Seymour is a longtime equity analyst at CNBC, and he also runs the Amplify Seymour Cannabis ETF (ARCX: CNBS). Seymour joins the podcast to talk about the...

The iShares Biotechnology ETF (NASDAQ: IBB), which includes several large cap biotechs, has recently narrowed its year-to-date loss to around 10%. On CNBC’s “Halftime Report Final Trades,” Jeffrey Mills of Bryn Mawr Trust recommended going long on biotech stocks. Check out...

On CNBC’s “The Final Call,” Carter Worth said that interest rate areas are “sensitive to what’s going on in the long end of the curve.” “I don’t like them,” he added. Worth said he was going short on both SPDR S&P Regional Banking ETF (...

Tim Seymour is the founder and Chief Investment Officer of Seymour Asset Management. It aims to provide clients with asset management and wealth management services, including direct investment and allocation to private equity and alternative assets. Seymour, a market expert and co-host of "...

That was the best night ever! That’s what many said coming away from an April 21 afterparty that marked the end of Benzinga’s Psychedelics and Cannabis Capital conferences. Hosted at Groot Hospitality and David Grutman’s LIV Nightclub, which is inside of the iconic...

On CNBC's "Fast Money Final Trades," Tim Seymour picked a long position in EOG Resources Inc (NYSE: EOG) as his final trade. Steve Grasso is a buyer of Trinseo S.A. (NYSE: TSE), Bonawyn Eison is bullish on VIX. He said volatility is starting to find a floor around 15. Jeff Mills wants...

On CNBC's "Fast Money Final Trade," Tim Seymour recommended a long position in iShares MSCI India ETF (BATS: INDA). Nadine Terman wants to buy Adyen Unsponsored Netherl 50 ADR (OTCMKTS: ADYEY). Pete Najarian said Marvell Technology Inc (NASDAQ: MRVL) has got a lot more room to the...

On CNBC's "Fast Money Final Trades," Tim Seymour said the whole story about Brazil is whether the currency is going to be improved. He sees good dividends in Brazil and certainly in Petroleo Brasileiro ADR (NYSE: PBR). Jeff Mills would be a buyer of D R Horton Inc (NYSE: DHI). The...

On CNBC's "Fast Money," Tim Seymour spoke about a possible break out in iShares Nasdaq Biotechnology ETF (NASDAQ: IBB). He said traders should be defensive in a high multiple environment and they're buying the ETF because in Amgen, Inc. (NASDAQ: AMGN) they have an exciting...